Our Team

TILT’s founder and CEO, Akseli Hemminki is a biotech entrepreneur and cancer clinician. He leads Tiltbio’s highly regarded and experienced team, which has grown to 20 professionals based in in Europe and the U.S., and with decades of experience in the research, development, and commercialization of cancer therapeutics.

Akseli Hemminki

MD, PhD, eMBA, Founder & CEO and Member of the Board of Directors

Aino Kalervo

MSc, MS, Chief Operating Officer

John Goldfinch

MBA, CRM, US Clinical Lead & CEO - TILT Biotherapeutics LLC

Suvi Sorsa

PhD, VP of Clinical Affairs

Tuija Keinonen

PhD, Prof, Chair of the Board of Directors, Chief Regulatory Officer

Kari Varkila

MD, PhD, MBA, Chief Medical Officer

Chad Hellmann

MBA, Capital Strategy - Advisor

Víctor Cervera-Carrascón

PhD, VP of Business Development

Hanna Kirk

MSc, VP of Product Development

Riikka Havunen

PhD, VP of Operations